CLINICAL_TRIALS
trial_result
· 2009-12-11
Clinical Trial Update: Fenofibrate Bioequivalence Study (0767-031) [Phase 1]
Summary
A Phase 1 bioequivalence study of fenofibrate for dyslipidemia has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2009-12-11